Research funder · United States
Children's Tumor Foundation
Foundation dedicated to improving the health and well-being of individuals and families affected by neurofibromatosis
- Grants since 2016
- 436
- Awarded, last 5 years (where amounts are published)
- 28.1M
- Funded works, last 5 years
- 115
- Funded works, all time
- 426
Grants
2021–2023 · award
Neural Underpinnings of Attention in Children with NF1
Sara Pardej
2021 · award
Duke University
David Van Mater
2021 · award
Seattle Children's Hospital
Aimee Sato
2021 · award
Children's Minnesota
Anne Bendel
2021 · award
Washington University/St. Louis Children's Hospital
David Gutmann
2021–2023 · award
Incorporating FDA Guidance on Patient-Focused Drug Development in NF: A Pilot Study of Qualitative Patient Interviews within NF Clinical Trials
Vanessa Merker
2021 · award
Children's National Hospital
Miriam Bornhorst
2021 · award
Boston Children's Hospital
David Miller
2021 · award
The Ohio State University
Oliver Adunka
2021 · award
DGSOM at UCLA
Phioanh Leia Nghiemphu
2021–2023 · award
Effectiveness of a Telehealth Group for Improving Peer Relationships for Adolescents with Neurofibromatosis Type 1
Bonita Klein-Tasman · University of Wisconsin–Milwaukee
2021–2022 · award
Evaluation of a PAK1-selective PROTAC, alone and with Hippo inhibitors, as a targeted therapy in NF2
Jonathan Chernoff · Fox Chase Cancer Center
2021 · award
AdventHealth for Children
Fouad Hajjar
2021–2022 · award
Preclinical Therapeutic Evaluation of ALY101 in a murine model of neurofibromatosis type 2
D Clapp · Indiana University (all Campuses)
2021 · award
Randall Children's Hospital and Legacy Emanuel Medical Center
Drea Petersen
2021 · award
University of North Carolina School of Medicine
Robert Greenwood
2021–2023 · award
Identification of modifier genes in LZTR1-associated schwannomatosis by whole exome sequencing
Laura Papi
2021 · award
University of Rochester Medical Center
Alex Paciorkowski
2021–2023 · award
The effects of RAS signaling pathway inhibitors on tumor cells and the tumor immune microenvironment in malignant peripheral nerve sheath tumors
Lindy Zhang
2021 · award
Children's Hospital Colorado
Jennifer Janusz
2021 · award
CHOA/Emory University
David Wolf
2021 · award
Arkansas Children's Hospital
Gregory Sharp
2021 · award
Massachusetts General Hospital
Justin Jordan
2021 · award
Children's Health/UT Southwestern Medical Center
Laura Klesse
2021–2023 · award
Adaptation of an evidence-based neurofibromatosis resiliency program for web-based delivery
Ethan Lester · Massachusetts General Hospital
2021 · award
Children's Hospital of Los Anegeles
Tena Rosser
2021 · award
Froedtert Cancer Center / Medical College of Wisconsin
Fernando Santos Pinheiro
2021 · award
Rutgers New Jersey Medical School
Beth Pletcher
2021–2024 · award
Maintenance of the NF Data Portal and CTF Grantee Data Sharing Support
Robert Allaway · Sage Bionetworks
2021–2026 · award
Renewal: Developing Evidence-Based Criteria for Initiating Treatment for NF1-OPG
Michael Fisher
2021–2023 · award
The Development and Validation of the NF Pain Module (NFPM) within iCanCope-NF Clinical Trial
Frank Buono
2021 · award
SSM Cardinal Glennon Children's Hospital
Veronica Stovall
2021 · award
Ann and Robert H. Lurie Children's Hospital of Chicago
Joel Charrow
2021 · award
The Children's Hospital of Philadelphia
Michael Fisher
2021 · award
CT Children's
Francis Dimario Jr
2021 · award
University of Oklahoma Health Sciences Center
Ashley Taylor
2021–2023 · award
NFCTC Data Management Support
Bruce Korf · University of Alabama at Birmingham
2021–2023 · award
Defining the RABL6A-YAP axis in MPNST pathogenesis and therapy
Jordan Kohlmeyer
2021 · award
Vanderbilt University Medical Center
Paul Moots
2021–2023 · award
Signaling pathways regulated by nitrated proteins as novel therapeutic targets for neurofibromatosis type 2
Isabelle Logan